CDH1 and ductal breast carcinoma in situ: In clinical practice, immunohistochemistry for E-cadherin is a helpful marker for differential diagnosis, since most cases of low-grade DCIS exhibit E-cadherin positivity, whereas LN is almost always E-cadherin negative [[136], reviewed in ([137]), ([138])].